India's pharmaceutical exports registered slowest growth in  15 years at 1.2% to $14.84 billion last fiscal amid growing tension with the US - India's biggest market - over intellectual property rights related issues. As the issues are unlikely to be resolved anytime soon, experts say that pharma exports will miss the target of $25 billion set for 2014-15.